Gail Maderis is President & CEO of BayBio, the industry organization representing and supporting Northern California’s life science community. As a former biotech CEO, Ms. Maderis brings deep experience and commitment to supporting the industry through enterprise development, peer-to-peer experience sharing, advocacy and support of education and workforce development. From 2003 to 2009, Ms. Maderis served as President and CEO of Five Prime Therapeutics, Inc., a privately held protein discovery and development company. At FivePrime, she successfully funded the company’s rapid growth through substantial private equity financings and corporate partnerships and took the company’s first novel cancer therapeutic from discovery into clinical trials. Prior to FivePrime, Ms. Maderis held senior executive positions at Genzyme Corporation, including founder and president of Genzyme Molecular Oncology (GZMO). Ms. Maderis practiced management and strategy consulting with Bain & Co. She serves on the boards of BayBio, the Mayor’s Biotech Advisory Council of San Francisco and the HBS Healthcare Initiative. She received a BS in business from the UC Berkeley and an MBA from Harvard Business School.
With more than 850 biotechnology companies, the Bay Area is the oldest, largest and most productive life sciences cluster in the world, employing more than 125,000 people in the region. For... Read more »
Entrepreneurship has fueled economic growth and innovation throughout the Bay Area’s history. We applaud President Barack Obama’s call to action and the White House Startup America program to support entrepreneurs. In... Read more »
The year that was 2010 was another year on the rollercoaster. We had our ups and our downs. But throughout, we continued to be at the forefront of innovation. From mature... Read more »
Proposition 24, on the November ballot, is all about jobs.
Prop. 24 will cost us as many as 322,000 jobs a year…next year, and for some years to come. Prop. 24... Read more »
Recently, Newsweek columnist Fareed Zakaria told an audience of biotechnology executives that America’s foothold as the preeminent technology innovator may be slipping.
“Bill Gates is the Britney Spears of China,” Zakaria... Read more »
1.Encourage tax incentives and policies that would create more investment in biotech. We should create a tax holiday to allow repatriation of offshore profits that are used to fund... Read more »
© 2007-2018, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.